Trade Secret Status Triggers Marketing Exclusivity For Chinese Drug Manufacturer
This article was originally published in The Pink Sheet Daily
Executive Summary
PharmAsia News examines how trade secret status impacts SFDA-regulated products, and how secret status differs from patent protection under the Chinese system.